From genetic testing to public health, Color now valued at $4.6B


The company started with genetic testing, but expanded to Covid-19 tests and vaccines during the pandemic. It’s valuation has tripled since it last raised a funding round valuing it at $1.5 billion in January.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.